Literature DB >> 18626734

Polypoidal choroidal vasculopathy with drusen.

Daisuke Iwama1, Akitaka Tsujikawa2, Manabu Sasahara1, Yasuhiko Hirami1, Hiroshi Tamura1, Nagahisa Yoshimura1.   

Abstract

PURPOSE: To study the prevalence and clinical features of drusen in eyes with polypoidal choroidal vasculopathy (PCV).
METHODS: Retrospectively, we reviewed the records of 98 consecutive patients with PCV (102 eyes). Drusen were examined in the inner macula, which was defined as an area within 1500 microm of the center of the fovea. Eyes that had at least one intermediate or large (>or=63 microm) soft drusen within the inner macula were defined as having drusen.
RESULTS: In these 102 eyes with PCV, 23 (23%) showed soft drusen in the inner macula. In such cases, the fellow eyes, those without a PCV lesion, sometimes also showed soft drusen in the inner macula (11 eyes); 34 (33%) of the eyes with PCV had soft drusen in the inner macula of at least one eye. Comparison of the group of eyes with PCV and drusen in one or both eyes with the group with PCV and no drusen in either eye revealed no significant difference in patient characteristics or in ocular manifestations.
CONCLUSIONS: Drusen are not an unusual feature of PCV, at least in Japanese patients, and, when present, they appear to have only a minor effect, if any, on the clinical course.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626734     DOI: 10.1007/s10384-007-0503-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  30 in total

1.  Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy.

Authors:  Masami Nakajima; Mitsuko Yuzawa; Hiroyuki Shimada; Ryusaburo Mori
Journal:  Jpn J Ophthalmol       Date:  2004 May-Jun       Impact factor: 2.447

2.  The origins of polypoidal choroidal vasculopathy.

Authors:  M Yuzawa; R Mori; A Kawamura
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

3.  Drusen as risk factors in age-related macular disease.

Authors:  D Pauleikhoff; M J Barondes; D Minassian; I H Chisholm; A C Bird
Journal:  Am J Ophthalmol       Date:  1990-01-15       Impact factor: 5.258

4.  Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.

Authors:  Rufino M Silva; João Figueira; M Luz Cachulo; Liliane Duarte; José R Faria de Abreu; J G Cunha-Vaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

5.  Idiopathic polypoidal choroidal vasculopathy in Japanese patients.

Authors:  M Uyama; T Matsubara; I Fukushima; H Matsunaga; K Iwashita; Y Nagai; K Takahashi
Journal:  Arch Ophthalmol       Date:  1999-08

6.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

7.  Polypoidal choroidal vasculopathy in Caucasians.

Authors:  B A Lafaut; A M Leys; B Snyers; F Rasquin; J J De Laey
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2000-09       Impact factor: 3.117

Review 8.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; J J Wang
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

9.  An update on multiple recurrent serosanguineous retinal pigment epithelial detachments in black women.

Authors:  B T Perkovich; Z N Zakov; L A Berlin; D Weidenthal; L R Avins
Journal:  Retina       Date:  1990       Impact factor: 4.256

10.  Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study.

Authors:  A Okubo; M Sameshima; A Uemura; S Kanda; N Ohba
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

View more
  5 in total

1.  Baseline data from a multicenter, 5-year, prospective cohort study of Japanese age-related macular degeneration: an AMD2000 report.

Authors:  Akitaka Tsujikawa; Yumiko Akagi-Kurashige; Mitsuko Yuzawa; Tatsuro Ishibashi; Hideo Nakanishi; Eiji Nakatani; Satoshi Teramukai; Masanori Fukushima; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2017-12-21       Impact factor: 2.447

Review 2.  Association of Genes in the High-Density Lipoprotein Metabolic Pathway with Polypoidal Choroidal Vasculopathy in Asian Population: A Systematic Review and Meta-Analysis.

Authors:  Ming-Zhen Yuan; Ruo-An Han; Chen-Xi Zhang; You-Xin Chen
Journal:  J Ophthalmol       Date:  2018-06-06       Impact factor: 1.909

3.  Associations of systemic, serum lipid and lipoprotein metabolic pathway gene variations with polypoidal choroidal vasculopathy in China.

Authors:  Ningda Xu; Hui Xu; Mingwei Zhao; Yongsheng Xu; Lvzhen Huang
Journal:  PLoS One       Date:  2019-12-26       Impact factor: 3.240

4.  Polypoidal Choroidal Vasculopathy in Congolese Patients.

Authors:  Nelly N Kabedi; David L Kayembe; Gloria M Elongo; Jean-Claude Mwanza
Journal:  J Ophthalmol       Date:  2020-01-18       Impact factor: 1.909

5.  Deep phenotype unsupervised machine learning revealed the significance of pachychoroid features in etiology and visual prognosis of age-related macular degeneration.

Authors:  Yoshikatsu Hosoda; Masahiro Miyake; Kenji Yamashiro; Sotaro Ooto; Ayako Takahashi; Akio Oishi; Manabu Miyata; Akihito Uji; Yuki Muraoka; Akitaka Tsujikawa
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.